Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4471699
Max Phase: Preclinical
Molecular Formula: C23H33N5O6S
Molecular Weight: 507.61
Molecule Type: Unknown
Associated Items:
ID: ALA4471699
Max Phase: Preclinical
Molecular Formula: C23H33N5O6S
Molecular Weight: 507.61
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C=C/C(C)=C/[C@@]1(C)SC(=O)C=C1OCC(=O)NCCn1cc(CNC(=O)[C@H](O)C(C)(C)CO)nn1
Standard InChI: InChI=1S/C23H33N5O6S/c1-6-15(2)10-23(5)17(9-19(31)35-23)34-13-18(30)24-7-8-28-12-16(26-27-28)11-25-21(33)20(32)22(3,4)14-29/h6,9-10,12,20,29,32H,1,7-8,11,13-14H2,2-5H3,(H,24,30)(H,25,33)/b15-10+/t20-,23+/m0/s1
Standard InChI Key: ZTNXSGFKCVTJGQ-IJFHWRKKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 507.61 | Molecular Weight (Monoisotopic): 507.2152 | AlogP: 0.45 | #Rotatable Bonds: 13 |
Polar Surface Area: 155.67 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.32 | CX Basic pKa: 0.05 | CX LogP: -0.23 | CX LogD: -0.23 |
Aromatic Rings: 1 | Heavy Atoms: 35 | QED Weighted: 0.28 | Np Likeness Score: -0.25 |
1. Bommineni GR, Kapilashrami K, Cummings JE, Lu Y, Knudson SE, Gu C, Walker SG, Slayden RA, Tonge PJ.. (2016) Thiolactomycin-Based Inhibitors of Bacterial β-Ketoacyl-ACP Synthases with in Vivo Activity., 59 (11): [PMID:27187871] [10.1021/acs.jmedchem.6b00236] |
Source(1):